Literature DB >> 18602239

Dual-time-point FDG PET for the evaluation of locoregional lymph nodes in thoracic esophageal squamous cell cancer.

Qinyong Hu1, Weixing Wang, Xiaojun Zhong, Shuanghu Yuan, Zheng Fu, Hongbo Guo, Jinming Yu.   

Abstract

PURPOSE: Compare dual-time-point and single-time 18F-FDG PET in the evaluation of locoregional lymph node metastases in patients with esophageal squamous cell cancer. Then assess the efficacy of dual-time-point PET in the diagnosis of such nodules.
METHODS: 34 patients with thoracic esophageal squamous cell cancer underwent dual-time-point PET before surgery. Semi-quantitative analysis was performed using the standardized uptake value (SUV), obtained from early and delayed images (SUVearly and SUVdelayed, respectively). The retention index (RI) calculated according to the equation: (SUVdelayed-SUVearly) x 100/SUVearly was assessed. Results were compared prospectively in relation to pathologic findings.
RESULTS: 71 of 354 resected nodal groups from 28 patients were confirmed positive by pathology. SUVearly of 2.5 and RI of 10 were chosen as arbitrary cutoffs for differentiating malignancy from benign, the sensitivity, specificity, accuracy, negative and positive predictive value of dual-time-point PET were 88.73% (63/71 nodal groups), 91.87% (260/283), 91.24% (323/354), 97.01% (260/268) and 73.25% (63/86) respectively, those of single-time were 76.06% (54/71), 85.16% (241/283), 83.33% (295/354), 93.41% (241/258) and 56.25% (54/96) respectively. P values were 0.047, 0.012, 0.002, 0.052 and 0.017 respectively, indicating remarkable differences in sensitivity, specificity, accuracy, and positive predictive value between dual-time-point and single-time PET.
CONCLUSION: Dual-time-point 18F-FDG PET has the potential for improving the sensitivity, specificity, accuracy and positive predictive value in the evaluation of locoregional lymph nodes in thoracic esophageal squamous cell cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18602239     DOI: 10.1016/j.ejrad.2008.05.009

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  10 in total

1.  Clinical significance of primary lesion FDG uptake for choice between oesophagectomy and endoscopic submucosal dissection for resectable oesophageal squamous cell carcinomas.

Authors:  Masatoyo Nakajo; Masayuki Nakajo; Atsushi Tani; Yoriko Kajiya; Shunji Shimaoka; Akio Matsuda; Tatsuyuki Nioh; Tohru Nihara; Toyokuni Suenaga; Sadao Tanaka; Hiroshi Shirahama; Michiyo Higashi; Chihaya Koriyama
Journal:  Eur Radiol       Date:  2011-07-13       Impact factor: 5.315

Review 2.  Defining the role of modern imaging techniques in assessing lymph nodes for metastasis in cancer: evolving contribution of PET in this setting.

Authors:  Thomas C Kwee; Sandip Basu; Drew A Torigian; Babak Saboury; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-01-12       Impact factor: 9.236

3.  The value of dual-time-point 18F-FDG PET/CT for identifying axillary lymph node metastasis in breast cancer patients.

Authors:  W H Choi; I R Yoo; J H O; S H Kim; S K Chung
Journal:  Br J Radiol       Date:  2010-11-16       Impact factor: 3.039

4.  Predictive value of 18F-fluorodeoxyglucose positron emission tomography - computed tomography compared to postoperative pathological findings for patients with non-small-cell lung cancer.

Authors:  Jie Xue; Jinsong Zheng; Hongbo Guo; Xiaohui Wang; Anqin Han
Journal:  Mol Clin Oncol       Date:  2014-09-04

Review 5.  Role of ¹⁸F 2-fluoro-2-deoxyglucose positron emission tomography in upper gastrointestinal malignancies.

Authors:  Elizabeth C Smyth; Manish A Shah
Journal:  World J Gastroenterol       Date:  2011-12-14       Impact factor: 5.742

Review 6.  When should we recommend use of dual time-point and delayed time-point imaging techniques in FDG PET?

Authors:  Gang Cheng; Drew A Torigian; Hongming Zhuang; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-01-30       Impact factor: 9.236

7.  False-Positive Cases of Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomographic Scans in Metastasis of Esophageal Cancer.

Authors:  Tomoki Yamatsuji; Naomasa Ishida; Munenori Takaoka; Jiro Hayashi; Kazuhiro Yoshida; Kaori Shigemitsu; Atsushi Urakami; Minoru Haisa; Yoshio Naomoto
Journal:  Clin Med Insights Case Rep       Date:  2017-04-10

8.  Current state of oncologic 18F-FDG PET/CT in Japan: A nationwide survey.

Authors:  Hajime Ichikawa; Toyohiro Kato; Kenta Miwa; Takayuki Shibutani; Koichi Okuda; Akio Nagaki; Hiroyuki Tsushima; Masahisa Onoguchi
Journal:  Asia Ocean J Nucl Med Biol       Date:  2021

9.  Use of benzodiazepines before (18)F-FDG-PET/CT dual-phase imaging does not decrease the efficacy of the study.

Authors:  Filiz Ozülker; Tamer Ozülker; Tevfik Ozpaçacı
Journal:  Indian J Nucl Med       Date:  2012-01

10.  18F-FDG PET/CT oncologic imaging at extended injection-to-scan acquisition time intervals derived from a single-institution 18F-FDG-directed surgery experience: feasibility and quantification of 18F-FDG accumulation within 18F-FDG-avid lesions and background tissues.

Authors:  Stephen P Povoski; Douglas A Murrey; Sabrina M Smith; Edward W Martin; Nathan C Hall
Journal:  BMC Cancer       Date:  2014-06-19       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.